Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular pathology of epithelial ovarian cancer.
Christie M, Oehler MK. Christie M, et al. Among authors: oehler mk. J Br Menopause Soc. 2006 Jun;12(2):57-63. doi: 10.1258/136218006777525794. J Br Menopause Soc. 2006. PMID: 16776856 Review.
Molecular genetics and endometrial cancer.
Oehler MK, Brand A, Wain GV. Oehler MK, et al. J Br Menopause Soc. 2003 Mar;9(1):27-31. doi: 10.1258/136218003100322116. J Br Menopause Soc. 2003. PMID: 12804310 Review.
Advances in the treatment of endometrial cancer.
Oehler MK, Fung A, Jobling TW. Oehler MK, et al. J Br Menopause Soc. 2005 Mar;11(1):18-22. doi: 10.1258/1362180053654547. J Br Menopause Soc. 2005. PMID: 15814058 Review.
Endometrial cancer.
Ryan AJ, Susil B, Jobling TW, Oehler MK. Ryan AJ, et al. Among authors: oehler mk. Cell Tissue Res. 2005 Oct;322(1):53-61. doi: 10.1007/s00441-005-1109-5. Epub 2005 Nov 3. Cell Tissue Res. 2005. PMID: 15947972 Review.
Ovarian status in healthy postmenopausal women.
Healy DL, Bell R, Robertson DM, Jobling T, Oehler MK, Edwards A, Shekleton P, Oldham J, Piessens S, Teoh M, Mamers P, Taylor N, Walker F. Healy DL, et al. Among authors: oehler mk. Menopause. 2008 Nov-Dec;15(6):1109-14. doi: 10.1097/gme.0b013e31816ddb6f. Menopause. 2008. PMID: 18536617
Whole-genome characterization of chemoresistant ovarian cancer.
Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S, Nones K, Cowin P, Alsop K, Bailey PJ, Kassahn KS, Newell F, Quinn MC, Kazakoff S, Quek K, Wilhelm-Benartzi C, Curry E, Leong HS; Australian Ovarian Cancer Study Group; Hamilton A, Mileshkin L, Au-Yeung G, Kennedy C, Hung J, Chiew YE, Harnett P, Friedlander M, Quinn M, Pyman J, Cordner S, O'Brien P, Leditschke J, Young G, Strachan K, Waring P, Azar W, Mitchell C, Traficante N, Hendley J, Thorne H, Shackleton M, Miller DK, Arnau GM, Tothill RW, Holloway TP, Semple T, Harliwong I, Nourse C, Nourbakhsh E, Manning S, Idrisoglu S, Bruxner TJ, Christ AN, Poudel B, Holmes O, Anderson M, Leonard C, Lonie A, Hall N, Wood S, Taylor DF, Xu Q, Fink JL, Waddell N, Drapkin R, Stronach E, Gabra H, Brown R, Jewell A, Nagaraj SH, Markham E, Wilson PJ, Ellul J, McNally O, Doyle MA, Vedururu R, Stewart C, Lengyel E, Pearson JV, Waddell N, deFazio A, Grimmond SM, Bowtell DD. Patch AM, et al. Nature. 2015 May 28;521(7553):489-94. doi: 10.1038/nature14410. Nature. 2015. PMID: 26017449
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.
Kang EY, Cheasley D, LePage C, Wakefield MJ, da Cunha Torres M, Rowley S, Salazar C, Xing Z, Allan P, Bowtell DDL, Mes-Masson AM, Provencher DM, Rahimi K, Kelemen LE, Fasching PA, Doherty JA, Goodman MT, Goode EL, Deen S, Pharoah PDP, Brenton JD, Sieh W, Mateoiu C, Sundfeldt K, Cook LS, Le ND, Anglesio MS, Gilks CB, Huntsman DG, Kennedy CJ, Traficante N; Australian Ovarian Cancer Study; DeFazio A, Kaufmann S, Churchman M, Gourley C, Stephens AN, Meagher NS, Ramus SJ, Antill YC, Campbell I, Scott CL, Köbel M, Gorringe KL; GAMuT Collaborators. Kang EY, et al. Mod Pathol. 2021 Jan;34(1):194-206. doi: 10.1038/s41379-020-0618-9. Epub 2020 Jul 28. Mod Pathol. 2021. PMID: 32724153 Free PMC article.
197 results